REVB Revelation Biosciences, Inc.
$3.73▲ +5.52%
Healthcare
Other
After hours
$3.73▲ +0.00%
Oct 27, 4:33 PM ET
Volume 14.7K
Avg Volume (10D) 38.3K
Key Metrics & Fundamentals
Market Cap
$2.12M
P/E Ratio
0.1
Div Yield
0.00%
52W Range
3.08 - 40.60
% vs 50 MA
-37.25%
% vs 200 MA
-55.93%
RSI-14
42.4
MACD Histogram
-0.0100
Beta (1Y vs SPY)
3.42
Free Cash Flow
-$2.60M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$3.65M
COGS
–
Operating Exp
$3.66M
Operating Income
-$3.66M
EBIT
-$3.66M
Pretax Income
-$3.32M
Net Income
-$3.32M
EPS (Diluted)
-0.87
Price & Volume History
Loading chart…
Recent News
Revelation Biosciences Announces 1-for-7 Reverse Stock Split Effective October 20, 2026
Business Wire · Oct 16, 2026 9:00 AM ET
Revelation Biosciences Selects Avance Clinical as CRO for Phase 2/3 TITAN Study
Business Wire · Aug 19, 2026 9:00 AM ET
REVB Approaching a Critical Inflection Point
Zacks Small Cap Research · Aug 7, 2026 8:14 AM ET
Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2026
ACCESS Newswire · Aug 6, 2026 4:15 PM ET
Independent Market Assessment Results Show $94 Billion Total Addressable Market for Gemini in Stage 2 and Stage 3 Acute Kidney Injury
ACCESS Newswire · Aug 3, 2026 9:00 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See REVB's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.